Specialty pharmaceutical company Supernus Pharmaceuticals (NASDAQ: SUPN) will be announcing earnings results this Tuesday after the bell. Here’s what to look for.
Supernus Pharmaceuticals beat analysts’ revenue expectations last quarter, reporting revenues of $209.9 million, up 20.5% year on year. It was a very strong quarter for the company, with a beat of analysts’ EPS estimates and a solid beat of analysts’ revenue estimates.
Is Supernus Pharmaceuticals a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, the market is expecting Supernus Pharmaceuticals’s revenue to grow 28.8% year on year, improving from the 12.7% increase it recorded in the same quarter last year.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Supernus Pharmaceuticals rarely misses Wall Street’s revenue estimates.
Looking at Supernus Pharmaceuticals’s peers in the branded pharmaceuticals segment, some have already reported their Q1 results, giving us a hint as to what we can expect. Eli Lilly delivered year-on-year revenue growth of 55.5%, beating analysts’ expectations by 13.7%, and Merck reported revenues up 4.9%, topping estimates by 3%. Eli Lilly traded up 13.2% following the results while Merck was also up 1%.
Read our full analysis of Eli Lilly’s results here and Merck’s results here.
There has been positive sentiment among investors in the branded pharmaceuticals segment, with share prices up 6% on average over the last month. Supernus Pharmaceuticals is down 5.3% during the same time and is heading into earnings with an average analyst price target of $62.67 (compared to the current share price of $47.85).
ALSO WORTH WATCHING: Nvidia’s Quiet Partner. Nvidia’s chips cost a hundred grand. The connectors that make them work cost even more. One company makes them all.
Every AI server needs specialized infrastructure the chip companies don’t make. High-speed cables. Power connectors. Thermal sensors. This 90-year-old company built a monopoly on it. The AI boom just started. This stock is still flying under the radar. Claim The Stock Ticker Here for FREE.
